![]() |
市场调查报告书
商品编码
1722611
脑积水分流器市场报告(按类型、产品类型、年龄层、最终用户和地区)2025 年至 2033 年Hydrocephalus Shunts Market Report by Type, Product Type, Age Group, End User, and Region 2025-2033 |
2024 年全球脑积水分流器市场规模达 4.672 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 6.421 亿美元,2025-2033 年期间的成长率 (CAGR) 为 3.42%。市场的主要驱动力是脑积水发病率的上升、先进的医疗保健基础设施以及分流器设计的技术创新。此外,先天性脑积水病例的增加和儿科人口的快速成长也极大地推动了市场的成长。
先天性病例和儿科人口不断增加
全球脑积水流器市场份额的一个显着趋势是婴儿和儿童先天性脑积水的盛行率不断增加。此外,儿科人口的快速成长也对市场动态起着举足轻重的作用。根据《世界统计》统计,全球每天有385,000名婴儿出生,即每年有1.4亿名婴儿出生。先天性病例的增加增加了儿科分流解决方案的需求。根据约翰霍普金斯医院统计,美国每出生1,000名婴儿中,就有1至2名患有先天性脑积水。因此,製造商目前正致力于为儿童和婴儿设计专门的分流器,以满足该年龄层独特的生理和解剖需求。
快速采用先进技术
全球脑积水分流器市场正经历采用先进技术的显着趋势,包括防虹吸和可程式分流器。这些创新透过精确调整脑脊髓液流量来改善患者的治疗效果。根据《神经外科杂誌》发表的一篇研究文章,在治疗脑积水方面,可程式分流器的修復率低于不可程式分流器。因此,可程式分流器被证明更具成本效益。研究表明,7% 的可程式分流器患者需要修復,而 21.6% 的不可编程分流器患者需要修復。此外,远端监控和远距医疗系统的结合将进一步推动其应用,改善术后护理并降低频繁就诊的需要。
新兴经济体产品普及率不断提高
全球脑积水市场份额在新兴市场呈现正面前景,主要原因是医疗支出增加和医疗基础设施增强。中国和印度等国家脑积水分流术的采用率正在提高,这主要是因为患者意识的提高和医疗设施的改善。根据产业报告,预计 2024 年亚太地区经济将强劲成长,其中印度 GDP 预计将成长 5%。政府采取措施加强医疗设施,以及主要公司在这些经济体中加强影响力,旨在满足未满足的医疗需求,进一步推动了市场扩张。
脑室腹膜占据大部分市场份额
脑室腹腔分流术 (VP) 占据了全球脑积水分流术市场的大部分份额,因为它可靠、高效,并且在临床应用中被广泛接受。 VP分流术在脑积水患者中表现出很高的成功率,有助于加强其在市场动态中的主导地位。 VP分流器在成人和儿科的广泛应用进一步促进了其市场的成长。根据临床报告,全球每年约有 75 万人被诊断出患有脑积水,而植入 16 万个 VP 分流器。此外,医疗专业人士的大力支持和有利的医疗政策有助于维持脑积水分流器的市场份额和成长。
脑积水瓣膜占据产业最大份额
脑积水瓣膜在调节脑脊髓液流动方面起着关键作用。瓣膜是脑积水流动系统的组成部分,因为它们有助于维持颅内压。可调节压力阀具有灵活的构造,旨在根据患者需求解决压力设定问题。固定压力阀的用途相对较少,但成本低廉且可靠。瓣膜製造技术的进步和创新进一步加强了该领域在全球脑积水分流器市场份额的成长。例如,Integra LifeSciences 透过製造各种固定压力阀(包括 Ultra VS 阀、Pudenz 阀、Mishler 开/关阀和 CODMAN HAKIM 精密固定压力阀)创新了阀门设计。
儿童是主要的细分市场
由于先天性脑积水盛行率较高以及对早期发现和治疗的需求强烈,儿童在全球脑积水分流器市场中占据最大份额。根据美国国立卫生研究院估计,全球每年将新增约 40 万例儿童脑积水病例。此外,根据《神经外科杂誌》发表的一篇研究文章,亚洲也是儿童脑积水的发生率较高的地区。研究中,亚洲地区非感染后脑积水的确诊率为 29%,感染后脑积水的确诊率为 10.7%。儿童神经外科的专门分流系统和发展在脑积水分流器市场动态中发挥关键作用。此外,对儿童神经退化性疾病的认识不断增强以及诊断技术的进步促进了该领域的主导地位。
医院在市场上占据明显主导地位
医院凭藉其优越的医疗基础设施、执行关键手术的能力以及称职的医疗保健专业人员,在全球脑积水分流器市场预测中占据最大的最终用户份额。医院因患者流量增加而获益匪浅,尤其是需要专门治疗的严重脑积水病例。根据脑积水协会的数据,每年有超过 4 万名儿童因脑积水入院,其中近 1 万名因分流功能障碍入院。此外,全面的术后护理和先进的技术等设施也巩固了他们在脑积水流量市场中的地位。此外,製造商和医院之间的策略合作伙伴关係促进了可靠的供应链,提高了后者在这一市场份额中的关键作用。
北美引领市场,占据脑积水分流器最大市场份额
该报告还对所有主要区域市场进行了全面的分析,包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。根据报告,北美是脑积水分流器最大的区域市场。
北美是全球脑积水分流器市场份额的主导地区,这主要是由于脑积水盛行率的增加和先进的医疗保健基础设施。根据 USF Health 统计,超过 80 万美国人患有脑积水,而患有失智症的患者中估计有 1%-5% 患有脑积水。该地区,尤其是美国,在研发领域和先进医疗技术的广泛应用方面处于领先地位。例如,位于印第安纳波利斯的印第安纳大学(IU)于2023年获得美国国立卫生研究院2.43亿美元的研究基金。 IU在研发方面发展迅速,并成立了脑积水研究中心,旨在寻找脑积水的解决方案。由于患者意识的提高和该国强有力的医疗保健政策,加拿大也对区域市场动态做出了巨大贡献。优惠的回报政策和根深蒂固的医疗保健提供者网路也加强了这种区域主导地位。
(请注意,这只是关键参与者的部分列表,完整列表在报告中提供。)
The global hydrocephalus shunts market size reached USD 467.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 642.1 Million by 2033, exhibiting a growth rate (CAGR) of 3.42% during 2025-2033. The market is primarily driven by the rising incidence of hydrocephalus, advanced healthcare infrastructure, and technological innovations in shunts design. Moreover, increasing cases of congenital hydrocephalus and rapid proliferation of pediatric population are significantly driving the market growth.
Increasing Congenital Cases and Pediatric Population
A significant trend in the global hydrocephalus shunts market share is the increasing prevalence of congenital hydrocephalus among infants and children. In addition, rapid growth in pediatric population is also playing a pivotal role in market dynamics. According to The World Counts, each day 385,000 babies are born, i.e., 140 million a year. The heightening incidents of congenital cases has boosted the demand for pediatric shunt solutions. According to John Hopkins Hospital, 1 or 2 of every 1000 infants born in U.S. have congenital hydrocephalus. As a result, manufacturers are currently emphasizing on designing specialized shunts for children and infants, acknowledging the distinct physiological and anatomical needs of this age group.
Rapid Adoption of Advanced Technologies
The global hydrocephalus shunts market is witnessing a notable trend towards the escalating adoption of advanced technologies, including anti-siphon and programmable shunts. Such innovations improve patient outcomes by permitting accurate adjustments of cerebrospinal fluid flow. According to a research article published in the Journal of Neurosurgery, programmable shunts depict lower revision rates than nonprogrammable shunts for the treatment of hydrocephalus. Consequently, programmable shunts are proven to be more cost-efficient. The research showed that 7% of patients with programmable shunts needed revisions, while 21.6% of patients with nonprogrammable shunts required revisions. Additionally, the incorporation of remote monitoring and telehealth systems is further driving adoption by improving post-operative care and lowering the need for frequent hospital visits.
Increasing Product Prevalence in Emerging Economies
The global hydrocephalus market share is witnessing a positive outlook in emerging market principally due to increase in healthcare spending and enhanced healthcare infrastructure. Countries like China and India are undergoing elevated adoption rates of hydrocephalus shunts primarily because of heightening patient awareness and improved medical facilities. As per industry reports, Asia Pacific is projected to depict a robust economic growth in 2024 with India's GDP estimated to grow by 5%. The market expansion is further propelled by government initiatives to enhance healthcare facilities and the strengthening presence of major companies in these economies, targeting to address the unmet medical demands.
Ventriculo-peritoneal accounts for the majority of the market share
The ventriculo-peritoneal (VP) represents the majority of the global hydrocephalus shunts market share as it is reliable, highly effective, and is largely accepted in clinical applications. VP shunts demonstrate high success rates in patients with hydrocephalus, aiding in strengthening its dominance in the market dynamics. The widespread utilization of VP shunts in adults as well as pediatrics further facilitate their market growth. As per a clinical report, approximately 750,000 individuals are diagnosed with hydrocephalus, while 160,000 VP shunts are implanted each year globally. Moreover, the robust support from medical professionals and advantageous healthcare policies assists in sustaining hydrocephalus shunts market share and growth.
Hydrocephalus valves hold the largest share of the industry
Hydrocephalus valves play a critical role in regulating the flow of cerebrospinal fluid. Valves are integral component of hydrocephalus shunt system as they aid in maintaining intracranial pressure. Adjustable pressure valves have flexible built, designed to address pressure settings as per the patient needs. Fixed pressure valves are comparatively less versatile but are cost-efficient and reliable. Advancements in manufacturing technology of valves and innovations further strengthen the segment's growth in the global hydrocephalus shunts market share. For instance, Integra LifeSciences has innovated the valves design by manufacturing various variants of fixed pressure valves, including Ultra VS valves, Pudenz Valves, Mishler On/Off valves, and CODMAN HAKIM Precision Fixed Pressure Valves.
Children represent the leading market segment
Children hold the largest segment in the global hydrocephalus shunts market share due to an elevated prevalence of congenital hydrocephalus and the intense demand for early detection and treatment. According to the National Institutes of Health, it is estimated that each year approximately 400,000 new cases of pediatric hydrocephalus will develop globally. Furthermore, according to a research article published in the Journal of Neurosurgey, Asia also depicts prevalence of pediatric hydrocephalus. In the study, 29% of nonpostinfectious hydrocephalus and 10.7% of postinfectious hydrocephalus were identified across Asia. Specialized shunt systems and development in pediatric neurosurgery for children plays a pivotal role in hydrocephalus shunts market dynamics. Additionally, intensifying awareness about neurogenerative diseases in children and enhanced diagnostics techniques facilitates the segment dominance.
Hospitals exhibit a clear dominance in the market
Hospitals hold the largest segment as an end user in the global hydrocephalus shunts market forecast because of their superior medical infrastructure, ability to execute critical surgeries, and competent healthcare professionals. Hospitals greatly profit from elevated patient inflow, particularly for critical hydrocephalus cases that demand specialized treatments. According to Hydrocephalus Association, pediatric hydrocephalus accounts for over 40,000 hospital admissions annually, with nearly 10,000 of these admissions resulting from shunt malfunctions. Moreover, facilities like thorough post-surgical care and advanced technologies also fortifies their position in the hydrocephalus shunt market dynamics. Additionally, strategic partnerships between manufacturers and hospitals facilitates a reliable supply chain, improving latter's pivotal role in this market share.
North America leads the market, accounting for the largest hydrocephalus shunts market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for hydrocephalus shunts.
North America is the dominant region in the global hydrocephalus shunts market share primarily due to increasing prevalence of hydrocephalus and cutting-edge healthcare infrastructure. According to USF Health, more than 800,000 Americans are suffering with hydrocephalus, while 1%-5% patients that are suffering with dementia are estimated to have hydrocephalus. The region, particularly United States, is leading in research and development sector and extensive utilization of advanced medical technologies. For instance, Indiana University (IU) in Indianapolis was granted with USD 243 million research fund from the National Institutes of Health in 2023. IU is growing rapidly in R&D and has established Hydrocephalus Research Center that aims to discover hydrocephalus solutions. Canada also has a substantial contribution in the regional market dynamics due to rising patient awareness and robust healthcare policies in the country. This regional domination is also strengthened by preferable pay back policies and an entrenched healthcare providers network.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)